Clinical Trial Update: Once Daily In-situ Forming Versus Twice-daily Conventional Metronidazole Vaginal Gels for Treatment of Bacterial Vaginosis [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 clinical trial comparing a once-daily in-situ forming vaginal gel to a twice-daily metronidazole vaginal gel for treating bacterial vaginosis has co…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bacterial Vaginosis

Drugs mentioned

• Metronidazole vaginal gel (metronidazole)
• in-situ forming vaginal gel (experimental formulation)

Snippet

Sponsor: Assiut University | Conditions: Vaginitis | Phase 2, Phase 3 | Status: COMPLETED